Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03587883 · ClinicalTrials.gov registry record · NA
Daily Intake of Cocoa Flavanols and Arterial Stiffness in Humans
A NA study, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03587883: Completed NA study, sponsored by University of California, Davis.
NCT03587883 is a NA study that has completed, run by University of California, Davis. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03587883, a NA study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
A randomized, double-masked and cross-over dietary intervention study to investigate the effects of diet supplementation with cocoa flavanols on arterial stiffness in healthy adult human subjects.
Primary Outcome
assessed as systolic blood pressure
Interventions
- OTHER Cocoa flavanols I
- OTHER Control I
- OTHER Cocoa flavanols II
- OTHER Control II
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-03-23 |
| Est. Completion | 2021-08-06 |
| Phase | NA |
What the finished NCT03587883 record still lists
NCT03587883 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 4 interventions - of which Cocoa flavanols I is the first listed.
NCT03587883 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03587883 about?
NCT03587883 is a clinical study titled "Daily Intake of Cocoa Flavanols and Arterial Stiffness in Humans". A randomized, double-masked and cross-over dietary intervention study to investigate the effects of diet supplementation with cocoa flavanols on arterial stiffness in healthy adult human subjects.
What is the current status of trial NCT03587883?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-03-23. Estimated completion is 2021-08-06.
What interventions are being tested in trial NCT03587883?
The interventions under investigation include: Cocoa flavanols I (OTHER), Control I (OTHER), Cocoa flavanols II (OTHER), Control II (OTHER).
Who is sponsoring clinical trial NCT03587883?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03587883's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI